{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:53:16Z","timestamp":1791967996183,"version":"4.3.4"},"reference-count":43,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis Care &amp; Research"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>In rheumatoid arthritis, the association between advanced therapies (including biologic disease\u2010modifying antirheumatic drugs [DMARDs] and targeted synthetic DMARDs) and methotrexate (MTX) is recommended by international societies. When MTX cannot be used, other conventional synthetic DMARDs (csDMARDs) may be proposed. We aimed to compare the safety and efficacy of MTX and non\u2010MTX csDMARDs in combination with advanced therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We systematically searched the literature for studies comparing the effectiveness, retention rate, and safety of MTX versus non\u2010MTX csDMARDs (leflunomide or others) in combination with tumor necrosis factor inhibitors (TNFi), abatacept, rituximab, tocilizumab, and JAK inhibitors. Meta\u2010analysis was performed with RevMan, using an inverse variance approach with fixed or random\u2010effects models. Risk ratios (RRs) and 95% confidence intervals (95% CIs) were estimated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The literature search revealed 3,842 articles; 41 studies were included for the systematic literature review and 21 for the meta\u2010analysis: 13 with TNFi, 3 with abatacept, and 5 with rituximab. For TNFi, the European Alliance of Associations for Rheumatology (EULAR) response at 6 months was lower for patients receiving non\u2010MTX csDMARDs than for those using MTX (RR 0.93 [95% CI 0.87, 1.0], <jats:italic>P<\/jats:italic> = 0.04; n = 3,843; I<jats:sup>2<\/jats:sup> = 28%), with a lower retention rate at 12\u00a0months. For abatacept, effectiveness and safety were similar between the 2 groups. For rituximab, a good EULAR response was higher with leflunomide than MTX (RR 1.38 [95% CI 1.13, 1.68], <jats:italic>P<\/jats:italic> = 0.001; n = 2,078; I<jats:sup>2<\/jats:sup> = 0%), with similar adverse event rates. Meta\u2010analysis for tocilizumab or JAK inhibitors could not be performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The different csDMARDs seem safe and efficient to combine with advanced therapies in RA patients. Although MTX seems slightly superior to other csDMARDs in combination with TNFi, leflunomide might be superior to MTX in combination with rituximab.<\/jats:p><\/jats:sec>","DOI":"10.1002\/acr.24195","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T07:04:05Z","timestamp":1585206245000},"page":"873-884","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Most Appropriate Conventional Disease\u2010Modifying Antirheumatic Drug to Combine With Different Advanced Therapies in Rheumatoid Arthritis: A Systematic Literature Review With Meta\u2010Analysis"],"prefix":"10.1002","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9765-5198","authenticated-orcid":false,"given":"Guillaume","family":"Decarriere","sequence":"first","affiliation":[{"name":"CHU Montpellier and Montpellier University  Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Barnetche","sequence":"additional","affiliation":[{"name":"University Hospital Pellegrin  Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Combe","sequence":"additional","affiliation":[{"name":"CHU Montpellier and Montpellier University  Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Gaujoux-Viala","sequence":"additional","affiliation":[{"name":"University Hospital Caremeau  N\u00eemes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Lukas","sequence":"additional","affiliation":[{"name":"CHU Montpellier and Montpellier University  Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7545-6385","authenticated-orcid":false,"given":"Jacques","family":"Morel","sequence":"additional","affiliation":[{"name":"CHU Montpellier and Montpellier University  Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Daien","sequence":"additional","affiliation":[{"name":"CHU Montpellier and Montpellier University  Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210715"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210602"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15640-7"},{"key":"e_1_2_7_5_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.20452\/pamw.1131","article-title":"Leflunomide in monotherapy of rheumatoid arthritis: meta\u2010analysis of randomized trials","volume":"122","author":"Golicki D","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-011-0478-8"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21830"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203229"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1349-y"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463201102400136"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-009-0187-8"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.066761"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.085696"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2084"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.139774"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.098467"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-005-0054-7"},{"issue":"2","key":"e_1_2_7_19_1","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/annrheumdis-2017-eular.2736","article-title":"Adalimumab in combination with non\u2010methotrexate conventional synthetic disease modifying rheumatic drugs in a clinical trial setting [abstract]","volume":"76","author":"Keystone E","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1488-5"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22070"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050524"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.099218"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-14"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200003"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.06.005"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110610"},{"key":"e_1_2_7_28_1","first-page":"76","article-title":"Effectiveness and safety of rituximab (RTX) monotherapy compared to RTX combination therapy with methotrexate or leflunomide in the German RTX\u2010treatment of active rheumatoid arthritis in daily practice trial [abstract]","volume":"68","author":"Wendler J","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"e_1_2_7_29_1","first-page":"536","article-title":"Rituximab combinations in rheumatoid arthritis patients : methotrexate versus leflunomide [abstract]","volume":"69","author":"Lukina G","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22327"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23940"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123392"},{"issue":"10","key":"e_1_2_7_33_1","article-title":"Is there any difference in RA patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic DMARDs in Turkbio Registry? [abstract]","volume":"69","author":"Inanc N","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13243"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-4-201308200-00006"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210094"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)00255-X"},{"key":"e_1_2_7_38_1","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.4049\/jimmunol.160.4.1581","article-title":"Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production","volume":"160","author":"Siemasko K","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.096743"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404922"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212537"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21519"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3708250"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4521"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facr.24195","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.24195","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/acr.24195","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.24195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T14:31:41Z","timestamp":1759415501000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr.24195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1002\/acr.24195"],"URL":"https:\/\/doi.org\/10.1002\/acr.24195","archive":["Portico"],"relation":{},"ISSN":["2151-464X","2151-4658"],"issn-type":[{"value":"2151-464X","type":"print"},{"value":"2151-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"2019-06-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}